Remove Blogging Remove Layoffs Remove Product Remove Technical Review
article thumbnail

Biotech Roundup: Kadmon Debt, Hemo Data, Loose Lips & More

Xconomy

Despite technical differences and the early nature of the data that made comparison difficult, Wall Street declared Spark this week’s winner. —The FDA approved a cholera vaccine , Vaxchora, giving Redwood City, CA-based PaxVax its second commercial product. UniQure’s shares fell more than 16 percent. right now. .

News 55
article thumbnail

Biotech Roundup: Hellos, Goodbyes, “Cures” Delays And Trial News

Xconomy

All eyes are on Holmes, who is scheduled to present data from the company’s technology at a medical conference on August 1. million Series A to develop a drug, licensed from Columbia University, for the brain cancer glioblastoma… Lyndra , a Cambridge startup working on oral drug delivery technology, has received $5.4

News 40
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

How will you ride the next wave?

Berkonomics

We use gestures or our voice to control our engagement with our technology. It won’t be long before another round of layoffs comes, and these new tools will create new jobs to fill the gap. None of this could be mined successfully in the past generation of technology. 62% look at online peer reviews.

Mobile 156
article thumbnail

Biotech Roundup: Moonshots, Pink Slips, Gilead, Brexit & More

Xconomy

At the gathering, Biden took verbal shots at scofflaw cancer researchers and at drug prices, while the FDA said it would take a shot at restructuring the way it evaluates oncology products. The technology was funded by the Department of Defense and comes from MIT’s Lincoln Lab. It also got a pat on the back from Bill Gates. .